2SHB 2320 — Concerning high THC cannabis products.

What this bill does

Includes legislative intent related to high-THC cannabis policy and funding, and requires the Department of Health to develop optional training for retail cannabis staff about health and safety impacts of high THC cannabis products. Increases the minimum legal age of sale of cannabis products with a THC concentration greater than 35 percent, to be age 25, with an exception for qualifying patients and designated providers. Requires the University of Washington Addictions, Drug & Alcohol Institute (ADAI) to develop and implement guidance and health interventions for health care providers and patients at risk for developing serious complications due to cannabis consumption, with reports to the Legislature, and subject to funding.

From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗

Floor votes

• House — 3rd Reading & Final Passage · February 9, 2024
  92 yea · 5 nay · 1 not voting
• House — Final Passage as Amended by the Senate · March 7, 2024
  94 yea · 3 nay · 1 not voting
• Senate — 3rd Reading & Final Passage as Amended by the Senate · March 7, 2024
  46 yea · 0 nay · 3 not voting
• Senate — 3rd Reading & Final Passage as Amended by the Senate · February 29, 2024
  47 yea · 1 nay · 1 not voting

Track 2SHB 2320 on OlympiaTrack

A free account adds a plain-English AI summary, the full hearing and amendment record, who testified, and roll calls by member. Plus email alerts when this bill moves.

Other bills sponsored by Davis

• HB 1696 — Concerning stalking-related offenses.
• E2SHB 1715 — Enacting comprehensive protections for victims of domestic violence and other violence involving family members or intimate partners.
• E2SHB 2311 — Supporting first responder wellness and peer support.
• 2SHB 2319 — Concerning substance use disorder treatment.